BIOLASE, Inc. , together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.
Biolase stock last closed at $0.15, up 0.68% from the previous day, and has decreased 99.44% in one year. It has underperformed other stocks in the Medical Devices industry by 0.83 percentage points. Biolase stock is currently +18.4% from its 52-week low of $0.13, and -99.56% from its 52-week high of $33.44.
At the moment, there are 32.52M shares of BIOL outstanding. The market capitalization of BIOL is $4.81M. In the last 24 hours, 587,882 BIOL shares were traded.
You need an online brokerage account to access the NASDAQ market and buy BIOL shares.
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal info so you are able to buy BIOL today.
Now that you have opened your account on the best stock app for beginners, you need to deposit funds:
Watch the tutorial below for more details depositing money into your brokerage account.
Once you have chosen the best place to buy Biolase stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk as well as the upside.
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on BIOL's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge BIOL's intrinsic value.
You can access additional valuation research on BIOL's stock here.
Out of 2 Equities analysts who research BIOL, the consensus analyst rating on Biolase is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Biolase stock forecast page.
Last year, BIOL revenue was $49.16M. Over the past five year, BIOL's revenue has increased by 1.27% per year. This was slower than the Medical Devices industry average of 13.47%.
Find out more about BIOL's earnings and revenue performance here.
In the last year, insiders at BIOL have not bought or sold any shares.
Get more info about who owns BIOL shares here.
No, Biolase doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two main types of orders:
Click the Open button and eToro will execute your order.
If you need more info about buying stocks on eToro, click the how to video below:
Now that you own some BIOL shares, you'll want to keep up with your investment.
Make a watchlist to track your BIOL stock.
To reiterate, here are the 6 steps to buy Biolase stock:
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep tabs on your investment in Biolase, click below.